<html>
<head>PUBMED IDs for MTO1</head>
<body bgcolor='#C5F0F2'><h1>MTO1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12011058/'>Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation.</a> May 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12939650/'>Lack of a modulative factor in locus 8p23 in a Finnish family with nonsyndromic sensorineural hearing loss associated with the 1555A&gt;G mitochondrial DNA mutation.</a> August 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14522080/'>Identification and characterization of mouse MTO1 gene related to mitochondrial tRNA modification.</a> October 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15509579/'>Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases.</a> October 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15542390/'>Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3.</a> November 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/18391568/'>Molecular characterization of putative modulatory factors in two Spanish families with A1555G deafness.</a> April 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19338775/'>Study of modifiers factors associated to mitochondrial mutations in individuals with hearing impairment.</a> April 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19460296/'>Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.</a> January 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23510774/'>Nuclear factors: roles related to mitochondrial deafness.</a> June 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23929671/'>MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast.</a> May 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24160266/'>Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.</a> June 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25149473/'>The ROS-sensitive microRNA-9/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome.</a> August 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25434004/'>Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy.</a> February 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25506927/'>MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25898254/'>MTO1 worked as a modifier in the aminoglycosides sensitivity of yeast carrying a mitochondrial 15S rRNA C1477G mutation.</a> April 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26061759/'>Optic neuropathy, cardiomyopathy, cognitive disability in patients with a homozygous mutation in the nuclear MTO1 and a mitochondrial MT-TF variant.</a> June 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27256614/'>The homozygous R504C mutation in MTO1 gene is responsible for ONCE syndrome.</a> June 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28520103/'>Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.</a> May 19  2017<br></body></html>
